Myriad to Acquire Psychiatry-focused PGx Firm Assurex

NEW YORK (GenomeWeb) – Myriad Genetics announced today that it plans to acquire mental health-focused pharmacogenetics firm Assurex Health for $225 million in upfront payments. The deal, which will grant Myriad entry into the neuroscience space, also includes the potential for $185 million in performance-based milestone payments, the company added.


Link to Full Article: Myriad to Acquire Psychiatry-focused PGx Firm Assurex

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!